Robot-assisted pyeloplasty for ureteropelvic junction obstruction: experience from a tertiary referral center.


Journal

Minerva urologica e nefrologica = The Italian journal of urology and nephrology
ISSN: 1827-1758
Titre abrégé: Minerva Urol Nefrol
Pays: Italy
ID NLM: 8503649

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 16 2 2019
medline: 21 8 2019
entrez: 16 2 2019
Statut: ppublish

Résumé

The aim of the study was to describe the surgical outcomes of a series of consecutive patients treated with robot-assisted pyeloplasty (RAP) for ureteropelvic junction obstruction in a single tertiary referral center. We prospectively collected and retrospectively analyzed data of 292 patients submitted to RAP performed from September 2011 to December 2016 by four experienced surgeons. The stenotic ureteropelvic junction was resected according to the Anderson-Hynes technique. Complications' severity was recorded and graded according to the modified Clavien classification system. The mean age was 40.6 years (SD15.5). Median Charlson Comorbidity Index was 0 (IQR 0-1). All interventions were performed with a transperitoneal access and a ureteral stent was always positioned. The mean operative time was 112.8 minutes (SD 48.7). Overall postoperative complications were 29 (9.9%): 24 (8.2%) surgical complications (7.2% Clavien 1, 0.7% Clavien 2 and 0.3% Clavien 3) and 5 (1.7%) medical complications (1% Clavien 1, 0.7% Clavien 2). The mean length of stay (LOS) was 4 days (SD 2.0). Median follow-up was 21 months (range 14-62). Six (2%) patients presented a recurrent obstruction with persistent hydronephrosis with or without symptoms or they had persistent symptoms. They were all submitted to retrograde holmium laser endopyelotomy. One (0.3%) of them required redo RAP for persistence of symptoms 8 months after the endoscopic treatment. In our experience, RAP with Anderson-Hynes technique performed in a tertiary referral center by expert surgeons represent a safe and feasible procedure with an overall low rate of postoperative complications.

Sections du résumé

BACKGROUND BACKGROUND
The aim of the study was to describe the surgical outcomes of a series of consecutive patients treated with robot-assisted pyeloplasty (RAP) for ureteropelvic junction obstruction in a single tertiary referral center.
METHODS METHODS
We prospectively collected and retrospectively analyzed data of 292 patients submitted to RAP performed from September 2011 to December 2016 by four experienced surgeons. The stenotic ureteropelvic junction was resected according to the Anderson-Hynes technique. Complications' severity was recorded and graded according to the modified Clavien classification system.
RESULTS RESULTS
The mean age was 40.6 years (SD15.5). Median Charlson Comorbidity Index was 0 (IQR 0-1). All interventions were performed with a transperitoneal access and a ureteral stent was always positioned. The mean operative time was 112.8 minutes (SD 48.7). Overall postoperative complications were 29 (9.9%): 24 (8.2%) surgical complications (7.2% Clavien 1, 0.7% Clavien 2 and 0.3% Clavien 3) and 5 (1.7%) medical complications (1% Clavien 1, 0.7% Clavien 2). The mean length of stay (LOS) was 4 days (SD 2.0). Median follow-up was 21 months (range 14-62). Six (2%) patients presented a recurrent obstruction with persistent hydronephrosis with or without symptoms or they had persistent symptoms. They were all submitted to retrograde holmium laser endopyelotomy. One (0.3%) of them required redo RAP for persistence of symptoms 8 months after the endoscopic treatment.
CONCLUSIONS CONCLUSIONS
In our experience, RAP with Anderson-Hynes technique performed in a tertiary referral center by expert surgeons represent a safe and feasible procedure with an overall low rate of postoperative complications.

Identifiants

pubmed: 30767492
pii: S0393-2249.19.03328-9
doi: 10.23736/S0393-2249.19.03328-9
doi:

Types de publication

Journal Article

Langues

eng

Pagination

168-173

Auteurs

Lorenzo Masieri (L)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Simone Sforza (S)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy - simone.sforza1988@gmail.com.

Andrea Mari (A)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Simone Morselli (S)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Riccardo Tellini (R)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Fabrizio Di Maida (F)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Graziano Vignolini (G)

Department of Urologic Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy.

Sergio Serni (S)

Department of Urologic Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy.

Marco Carini (M)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Andrea Minervini (A)

Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH